Brazil · Delayed Price · Currency is BRL Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of BRL 807.80 billion. The enterprise value is 1.05 trillion.
| Market Cap | 807.80B |
| Enterprise Value | 1.05T |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Jan 22, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 66.24% |
| Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 18.87 and the forward PE ratio is 9.17.
| PE Ratio | 18.87 |
| Forward PE | 9.17 |
| PS Ratio | 2.34 |
| PB Ratio | 1.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 24.63 |
| EV / Sales | 3.23 |
| EV / EBITDA | 7.86 |
| EV / EBIT | 10.54 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | n/a |
| Interest Coverage | 7.17 |
Financial Efficiency
Return on equity (ROE) is 8.58% and return on invested capital (ROIC) is 13.68%.
| Return on Equity (ROE) | 8.58% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.68% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.70% |
| Revenue Per Employee | 4.26M |
| Profits Per Employee | 528,428 |
| Employee Count | 81,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.47B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.61% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -8.61% |
| 50-Day Moving Average | 34.47 |
| 200-Day Moving Average | 33.67 |
| Relative Strength Index (RSI) | 55.86 |
| Average Volume (20 Days) | 15,728 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, Pfizer had revenue of BRL 344.69 billion and earned 42.80 billion in profits. Earnings per share was 7.51.
| Revenue | 344.69B |
| Gross Profit | 261.29B |
| Operating Income | 105.55B |
| Pretax Income | 41.43B |
| Net Income | 42.80B |
| EBITDA | 141.49B |
| EBIT | 105.55B |
| Earnings Per Share (EPS) | 7.51 |
Balance Sheet
The company has 82.54 billion in cash and 341.15 billion in debt, with a net cash position of -258.61 billion.
| Cash & Cash Equivalents | 82.54B |
| Total Debt | 341.15B |
| Net Cash | -258.61B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 512.77B |
| Book Value Per Share | 89.90 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.
| Gross Margin | 75.81% |
| Operating Margin | 30.62% |
| Pretax Margin | 12.02% |
| Profit Margin | 12.42% |
| EBITDA Margin | 41.05% |
| EBIT Margin | 30.62% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 4.49%.
| Dividend Per Share | 1.58 |
| Dividend Yield | 4.49% |
| Dividend Growth (YoY) | -3.58% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 4.27% |
| Earnings Yield | 5.30% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 29, 2020. It was a forward split with a ratio of 4.
| Last Split Date | Oct 29, 2020 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |